Scholars in marketing develop new and better techniques for allocating marketing expenditures. Implicit in this endeavor is the belief that it matters both how much and well marketing and sales spending is deployed. This exploratory research study provides estimates of the contributions of the quantity and quality of expenditures on commercial operations to business performance by using a unique, company-level dataset that contains the internal marketing expenditures of 26 pharmaceutical firms from 2005 to 2011. As expected, the empirical results reveal that increasing marketing and sales expenditures positively affects business performance. However, consistent with the notion that the quality of spending matters in addition to the spending level, commercial organizational attributes that are positively related to expenditure quality (innovation and execution in commercial operations) interact synergistically with marketing expenditures, increasing the return on expenditures. Further, changes in commercial operations innovation and execution operate synergistically to affect business performance. We provide specific managerial recommendations that demonstrate the importance of formulating a strategic vision that governs not only how much to spend in commercial operations support, but also investing in advanced employee skills and processes that foster a culture of innovation excellence and execution prowess in marketing and sales and departments.
SrinivasanSHanssensD. Marketing and firm value: metrics, methods, findings, and future directions. J Market Res2009; 46: 293–312.
5.
VorhiesDMorganRAutryC. Product-market strategy and the marketing capabilities of the firm: impact on market effectiveness and cash flow performance. Strateg Manage J2009; 30: 1310–1334.
SrivastavaRReibsteinDWoodsideW. Metrics for linking marketing to financial performance, Cambridge, MA: Marketing Science Institute, 2005.
8.
VerhoefPLeeflangP. Understanding the marketing department’s influence within the firm. J Marketing2009; 73: 14–37.
9.
KrasnikovAJayachandranS. The relative impacts of marketing, research-and-development, and operations capabilities on firm performance. J Marketing2008; 72: 1–11.
10.
HanssensDRustRSrivastavaR. Marketing strategy and Wall Street: nailing down marketing’s impact. J Marketing2009; 73: 115–118.
11.
BeckerGMurphyKTamuraRHuman capital, fertility, and economic growth. In: BeckerG (ed). Human capital: a theoretical and empirical analysis with special reference to education, Chicago: The University of Chicago Press, 1994, pp. 323–350.
12.
MantralaMSinhaPZoltnersA. Impact of resource allocation rules on marketing investment-level decisions and profitability. J Market Res1992; 29: 162–175.
13.
PammolliFMagazzinoLRiccaboniM. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov2011; 10: 428–438.
StremerschSVan DyckW. Marketing of the life sciences: a new framework and research agenda for a nascent field. J Marketing2009; 73: 4–30.
16.
Abou-GharbiaMChildersW. Discovery of innovative therapeutics: today’s realities and tomorrow’s vision. 1. Criticisms faced by the pharmaceutical industry. J Med Chem2013; 56: 5659–5672.
ChressanthisGKhedkarPJainN. Can access limits on sales representatives to physicians affect clinical prescription decisions? A study of recent event with diabetes and lipid drugs. J Clin Hypertens2012; 14: 217–226.
19.
ChressanthisGSfekasAKhedkarP. Determinants of pharmaceutical sales representative access limits to physicians. J Med Marketing2014; 14: 220–243.
20.
ZoltnersASinhaPLorimerS. Building a winning sales force: powerful strategies for driving high performance, New York: American Management Association, 2009.
RuberaGKircaA. Firm innovativeness and its performance outcomes: a meta-analytic review and theoretical integration. J Marketing2012; 76: 130–147.
23.
SorescuAChandyRPrabhuP. Sources of financial consequences of radical innovation: Insights from pharmaceuticals. J Marketing2003; 67: 82–102.
24.
GriffinAHauserJ. Integrating R&D and marketing: a review and analysis of the literature. J Prod Innovat Manag1996; 13: 191–215.
25.
EvansKLandryTLiP. How sales controls affect job-related outcomes: the role of organizational sales-related psychological climate perceptions. J Acad Market Sci2007; 35: 445–459.
26.
MatsuoM. The influence of sales management control on innovativeness of sales departments. J Pers Selling Sales Manag2009; 29: 321–331.
27.
GuenziPTroiloG. The joint contribution of marketing and sales to the creation of superior customer value. J Bus Res2007; 60: 98–107.
28.
RouzièsDAndersonEKohliA. Sales and marketing integration: a proposed framework. J Pers Selling Sales Manag2005; 25: 113–122.
29.
NaylorGFrankK. The impact of retail sales force responsiveness on consumers’ perceptions of value. J Serv Mark2000; 14: 310–322.
30.
StrahleWSpiroRAcitoF. Marketing and sales: strategic alignment and functional implementation. J Pers Selling Sales Manag1996; 16: 1–20.
31.
WebsterFJr. The changing role of marketing in the corporation. J Marketing1992; 56: 1–17.
32.
ZoltnersASinhaPLorimerS. Sales force effectiveness: a framework for researchers and practitioners. J Pers Selling Sales Manag2008; 28: 115–131.
33.
ZoltnersASinhaPLorimerS. Building a winning sales management team: the force behind the sales force, Evanston, IL: ZS Associates, 2012.
34.
RichG. The sales manager as a role model: effects on trust, job satisfaction, and performance of salespeople. J Acad Market Sci1997; 25: 319–328.
35.
AhearneMHaumannTKrausF. It’s a matter of congruence: how interpersonal identification between sales managers and salespersons shape sales success. J Acad Mark Sci2013; 41: 625–648.
36.
GrossmanSCottonR. Roche group’s sales organization models long-term sales force effectiveness. J Organ Excell2004; 24: 39–45.
37.
TrueloveC. 26th annual report: top 50 pharma companies. Med Ad News2012; 31: 6–22.
38.
NightingaleP. Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D. Ind Corp Change2000; 9: 315–359.
